Veille Scientifique

La veille scientifique est un nouveau service proposé par la SNFGE. Elle se veut un recensement rapide et assez exhaustif des articles publiés dans les revues majeures (New England Journal of Medicine, Lancet, JAMA, Gastroenterology, Gut, Lancet Oncology, Journal of Clinical Oncology, Hepatology, Journal of Hepatology, Endoscopy, Gastrointestinal Endoscopy...).
 

Patrice PIENKOWSKI
 Coordinateur

Six groupes animés par un responsable se chargent de ce travail tous les mois :

Cancers Endoscopie Foie/
VB
Gastro/
Procto/

Nutrition
MICI Pancréas
R. FAROUX E. CORON C. SILVAIN P. JOUET S. NAHON V. REBOURS
T. APARICIO
B. DENIS
S. MANFREDI
Y. TOUCHEFEU
D. TOUGERON

C. CELLIER
E. CHABRUN
F. ROSTAIN
JM. ROUILLON

B. HANSLIK
JL. PAYEN
JM. PERON
D. VALLA

H. DAMON
P. DUCROTTE
F. CORDET
V. COSTIL
P. COULOM
V. de PARADES
F. ZERBIB

V. ABITBOL
P. FAURE
P. MARTEAU
B. PARIENTE
P. SEKSIK
M. CAMUS
P. DELASALLE
L. de MESTIER


Nous espérons de ce nouvel outil qu’il vous aide à accéder rapidement et sélectivement aux données nouvelles de notre discipline selon vos sujets d’intérêt, qu’ils soient larges ou très spécifiques.

Revue Titre Date Coup de coeur Thématique
Gut Comparing histological activity indexes in UC sep. 15 3 ♥ MICI
British journal of Cancer Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2) sep. 15 2 ♥ Cancers autres (hors CCR et CHC), Œsophage/Estomac
Gut Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer sep. 15 4 ♥ Cancer colorectal (CCR)
Gut Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer sep. 15 2 ♥ Cancer colorectal (CCR)
Gut hTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation sep. 15 1 ♥ Cancers autres (hors CCR et CHC)
Gut Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy) sep. 15 5 ♥ Endoscopie/Imagerie, Cancer colorectal (CCR)
Endoscopy Clinical outcomes of endoscopic submucosal dissection for superficial esophageal neoplasms: a multicenter retrospective cohort study sep. 15 3 ♥ Endoscopie/Imagerie, Œsophage/Estomac, Cancers autres (hors CCR et CHC)
The Lancet Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial sep. 15 4 ♥ Foie, Chirurgie
Gut Kyoto global consensus report on Helicobacter pylori gastritis sep. 15 4 ♥ Œsophage/Estomac
Hepatology Long-term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects sep. 15 2 ♥ Foie
Hepatology Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C-Infected Patients With Compensated and Decompensated Cirrhosis sep. 15 3 ♥ Foie
The Lancet Primary biliary cirrhosis sep. 15 3 ♥ Foie
Journal of Hepatology Laparoscopic versus open liver resection for hepatocellular carcinoma: Case-matched study with propensity score matching sep. 15 5 ♥ Foie, Carcinome hépatocellulaire (CHC), Chirurgie
New England Journal of Medicine (NEJM) Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component sep. 15 4 ♥ Foie
Journal of Hepatology Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension sep. 15 5 ♥ Foie
The Lancet Oncology Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial sep. 15 4 ♥ Cancer colorectal (CCR)
The Lancet Oncology Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial sep. 15 4 ♥ Carcinome hépatocellulaire (CHC)
The Lancet Oncology Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial sep. 15 3 ♥ Cancers autres (hors CCR et CHC), Cancer colorectal (CCR), Carcinome hépatocellulaire (CHC)
The Lancet Oncology Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial sep. 15 4 ♥ Cancers autres (hors CCR et CHC), Œsophage/Estomac
Hepatology Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort) sep. 15 4 ♥ Foie
Gut Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations sep. 15 1 ♥ Intestin/Nutrition/Troubles fonctionnels
Gastroenterology Prevention of Dabigatran-Related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study sep. 15 4 ♥ Œsophage/Estomac
Gastroenterology A Prediction Rule for Risk Stratification of Incidentally Discovered Gallstones: Results From a Large Cohort Study sep. 15 3 ♥ Foie
Gastroenterology Hepatitis C Virus Infection is Associated With Increased Cardiovascular Mortality: A Meta-analysis of Observational Studies sep. 15 3 ♥ Foie, Hépatites virales
Gut Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial. sep. 15 2 ♥ Estomac

Pages